In this study, delanzomib induced apoptosis, sensitized cells to doxorubicin-induced apoptosis, and upregulated key proteins such as p53, p38, and JNK in multiple cervical cancer cell lines via proteasome inhibition. The gene discussed is MAPK8; the disease is cervical carcinoma.